Drugmaker says allergy vaccine shows good early results

(Reuters) UPDATED 2009-08-04

According to Swiss drugmaker Cytos, the allergy vaccine CYT003-QbG10 has proven to be effective in mid-stage clinical studies. Researchers for the company say patients who took the drug had fewer allergy symptoms and reported a better quality of life than patients taking a placebo. Read full story >

See all Allergy News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Drugmaker says allergy vaccine shows good early results

People who read this also read...

What the community is saying...

Q & A on Drug Reactions: Was it an Allergic or Non-Allergic Type of Reaction?

James Thompson, MD